The palm phytonutrient supplier will show STGaia, TocoGaia, and PetGaia at the event and preview a planned research grant program.
|Articles|April 18, 2012
Nutraceuticals Int’l Group in Tijuana
Advertisement
Nutraceuticals International Group (Paramus, NJ) has opened an office in Tijuana to serve customers in Mexico and Latin America.
In Latin America, the company will focus on a Total Quality Management policy, covering raw material control, traceability, technical documents, FDA GMP compliance, and other standards.
Advertisement
Related to this article
Formulators are moving toward botanicals like ashwagandha, bacopa, saffron, and PEA that target the stress, cortisol, and nervous-system pathways behind restless nights.
Emerging plant protein sources are redefining how protein products are formulated.
The four-formula line is Olly’s second retailer-exclusive launch this year, following the launch of a probiotic range in April.
A randomized, double-blind, placebo-controlled trial in reproductive-age women found that 8 weeks of standardized shatavari extract supplementation was associated with improvements in sexual function, vaginal moisture, fatigue, and sleep disturbance.
The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.
The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Powerful Plants
2
Olly Launches Mochi Bites Supplements in Beauty, Sleep, Multi, and Energy
3
Beyond the Symptom: How Botanicals Are Redefining the Sleep Health Category
4
Meeting the Demand for Cleaner, Easier Sports Nutrition: The Case for Next-Gen Beta-Alanine
5